Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes
The New Zealand obese (NZO) mouse is a polygenic model for obesity and diabetes with obese females and obese, diabetes-prone males, used to study traits of the metabolic syndrome like type 2 diabetes mellitus (T2DM), obesity, and dyslipidaemia. By using LC-MS/MS, we here examine the suitability of t...
Saved in:
Main Authors: | Anna Weiser, Pieter Giesbertz, Hannelore Daniel, Britta Spanier |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/1864865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glyoxylate, a New Marker Metabolite of Type 2 Diabetes
by: Victoria J. Nikiforova, et al.
Published: (2014-01-01) -
Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease and vascular parkinsonism
by: A. A. Makarova, et al.
Published: (2025-01-01) -
Specific plasma metabolite profile in intestinal Behçet’s syndrome
by: Cheng-cheng Hou, et al.
Published: (2025-01-01) -
Hypoglycemic effects of black brick tea with fungal growth in hyperglycemic mice model
by: Wei Xu, et al.
Published: (2022-05-01) -
Insulin Therapy in Diabetic Hyperglycemic Emergencies
by: Diana Machado Ramírez, et al.
Published: (2014-09-01)